{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:39:20Z","timestamp":1791639560272,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010253","name":"Secretar\u00eda de Ciencia y T\u00e9cnica, Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["20020170100363BA"],"award-info":[{"award-number":["20020170100363BA"]}],"id":[{"id":"10.13039\/501100010253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 3080"],"award-info":[{"award-number":["PICT 3080"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00705-022-05555-y","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T14:25:13Z","timestamp":1659536713000},"page":"2203-2212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Inhibition of dengue virus infection by trifluoperazine"],"prefix":"10.1007","volume":"167","author":[{"given":"Luana E.","family":"Piccini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Castilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3404-8777","authenticated-orcid":false,"given":"Elsa B.","family":"Damonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"5555_CR1","doi-asserted-by":"publisher","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen SI, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI (2013) The global distribution and burden of dengue. Nature 496:504-507.https:\/\/doi.org\/10.1038\/nature12060","DOI":"10.1038\/nature12060"},{"key":"5555_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","volume":"385","author":"MG Guzm\u00e1n","year":"2015","unstructured":"Guzm\u00e1n MG, Harris E (2015) Dengue. Lancet 385:453\u2013465. https:\/\/doi.org\/10.1016\/S0140-6736(14)60572-9","journal-title":"Dengue. Lancet"},{"key":"5555_CR3","doi-asserted-by":"publisher","unstructured":"Guzm\u00e1n MG, Alvarez M, Halstead SB (2013) Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol158:1445-1459.https:\/\/doi.org\/10.1007\/s00705-013-1645-3","DOI":"10.1007\/s00705-013-1645-3"},{"key":"5555_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14760584.2017.1335201","volume":"7","author":"B Guy","year":"2017","unstructured":"Guy B, Noriega F, Ochiai RL, L\u2019azou M, Delore V, Skipetrova A, Verdier F, Coudeville L, Savarino S, Jackson N (2017) A recombinant live attenuated tetravalent vaccine for the prevention of dengue. Expert Rev Vaccines 7:1\u201313. https:\/\/doi.org\/10.1080\/14760584.2017.1335201","journal-title":"Expert Rev Vaccines"},{"key":"5555_CR5","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1080\/21645515.2019.1658503","volume":"15","author":"ST Thomas","year":"2019","unstructured":"Thomas ST, Yoon I-K (2019) A review of Dengvaxia\u00ae: development to deployment. Hum Vaccin Immunother 15:2295\u20132314. https:\/\/doi.org\/10.1080\/21645515.2019.1658503","journal-title":"Hum Vaccin Immunother"},{"key":"5555_CR6","doi-asserted-by":"publisher","unstructured":"Troost B, Smit JM (2020) Recent advances in antiviral drug development towards dengue virus. CurrOpinVirol43:1-13.https:\/\/doi.org\/10.1016\/j.coviro.2020.07.009","DOI":"10.1016\/j.coviro.2020.07.009"},{"key":"5555_CR7","doi-asserted-by":"publisher","unstructured":"Borges MC, Castro LA, Fonseca BA (2013)Chloroquine use improves dengue-related symptoms. Mem Inst Oswaldo Cruz 108:596-599.https:\/\/doi.org\/10.1590\/S0074-02762013000500010","DOI":"10.1590\/S0074-02762013000500010"},{"key":"5555_CR8","doi-asserted-by":"publisher","unstructured":"Nguyen NM, Tran CNB, Phung LK, Duong KTH, HuynhHA, Farrar J, Nguyen QTH, Tran HT, Nguyen CVV, Merson L, Hoang LT, Hibberd ML, Aw PPK, Wilm A, Nagarajan N, Nguyen DT, Pham MP, Nguyen TT, Javanbakht H, Klumpp K, Hammond J, Petric R, Wolbers M, Nguyen CT, Simmons CP (2013) A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis 207:1442-1450.https:\/\/doi.org\/10.1093\/infdis\/jis470","DOI":"10.1093\/infdis\/jis470"},{"key":"5555_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004851","volume":"10","author":"C Sung","year":"2016","unstructured":"Sung C, Wei Y, Watanabe S, Lee HS, Khoo YM, Fan L, Rathore APS, Chan KW-K, Choy MM, Kamaraj US, Sessions OM, Aw P, de Sessions PF, Lee B, Connolly JE, Hibberd ML, Vijaykrishna D, Wijaya L, Ooi EE, Low JG-H, Vasudevan SG (2016) Extended evaluation of virological, immunological and pharmacokinetic endpoints of CELADEN: a randomized, placebo-controlled trial of celgosivir in dengue fever patients. PLoSNeglTropDis 10:e0004851. https:\/\/doi.org\/10.1371\/journal.pntd.0004851","journal-title":"PLoSNeglTropDis"},{"key":"5555_CR10","doi-asserted-by":"publisher","unstructured":"Tam DTH, Ngoc TV, Tien NTH, Kieu NTT, Thuy TTT, Thanh LTC, Tam CT, Truong NT, Dung NT, Qui PT, Hien TT, Farrar J, Simmons CP, Wolbers M, Wills BA (2012) Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis 55:1216-1224.https:\/\/doi.org\/10.1093\/cid\/cis655","DOI":"10.1093\/cid\/cis655"},{"key":"5555_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000785","volume":"4","author":"V Tricou","year":"2010","unstructured":"Tricou V, Minh NN, Van TP, Lee SJ, Farrar J, Wills B, Tran HT, Simmons CP (2010) A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoSNeglTropDis 4:e785. https:\/\/doi.org\/10.1371\/journal.pntd.0000785","journal-title":"PLoSNeglTropDis"},{"key":"5555_CR12","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/cid\/civ949","volume":"62","author":"J Whitehorn","year":"2016","unstructured":"Whitehorn J, Nguyen CVN, Khanh LP, Kien DTH, Quyen NTH, Tran NTT, Hang NT, Truong NT, Tai LTH, Huong NTC, Nhon VT, Tram TV, Farrar J, Wolbers M, Simmons CP, Wills B (2016) Lovastatin for the treatment of adult patients with dengue: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 62:468\u2013476. https:\/\/doi.org\/10.1093\/cid\/civ949","journal-title":"Clin Infect Dis"},{"key":"5555_CR13","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.21873\/anticanres.12045","volume":"37","author":"B Varga","year":"2017","unstructured":"Varga B, Csonka A, Csonka A, Moln\u00e1r J, Amaral L, Spengler G (2017) Possible biological and clinical applications of phenothiazines. Anticancer Res 37:5983\u20135993. https:\/\/doi.org\/10.21873\/anticanres.12045","journal-title":"Anticancer Res"},{"key":"5555_CR14","doi-asserted-by":"publisher","unstructured":"Weiss B, Prozialeck WC, Wallace TL (1982) Interaction of drugs with calmodulin. Biochemical, pharmacological and clinical implications. BiochemPharmacol31:2217-2226.https:\/\/doi.org\/10.1016\/0006-2952(82)90104-6","DOI":"10.1016\/0006-2952(82)90104-6"},{"key":"5555_CR15","doi-asserted-by":"publisher","unstructured":"Pluta K, Morak-Mlodawska B, Jelen M (2011) Recent progress in biological activities of synthesized phenotiazines. Eur J Med Chem 46:3179-3189.https:\/\/doi.org\/10.1016\/j.ejmech.2011.05.013","DOI":"10.1016\/j.ejmech.2011.05.013"},{"key":"5555_CR16","doi-asserted-by":"publisher","unstructured":"Chockalingam K, Simeon RL, Rice CM, Chen Z (2010) A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle. Proc Natl AcadSci USA107:3764-3769. https:\/\/doi.org\/10.1073\/pnas.0915117107","DOI":"10.1073\/pnas.0915117107"},{"key":"5555_CR17","doi-asserted-by":"publisher","unstructured":"Gastaminza P, Whitten-Bauer C, Chisari FV (2010) Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection. ProcNatlAcadSci USA 107:291-296. www.pnas.org\/cgi\/doi\/https:\/\/doi.org\/10.1073\/pnas.0912966107","DOI":"10.1073\/pnas.0912966107"},{"key":"5555_CR18","doi-asserted-by":"publisher","unstructured":"Simanjuntak Y, Liang JJ, Lee YL, Lin YL (2015) Repurposing of prochlorperazine for use against dengue virus infection. J Infect Dis 211:394-404.https:\/\/doi.org\/10.1093\/infdis\/jiu377","DOI":"10.1093\/infdis\/jiu377"},{"key":"5555_CR19","doi-asserted-by":"publisher","unstructured":"Bohn W, Rutter G, Hohenberg H, Mannweiler K (1983) Inhibition of measles virus budding by phenotiazines. Virology 130:40-55.https:\/\/doi.org\/10.1016\/0042-6822(83)90116-2","DOI":"10.1016\/0042-6822(83)90116-2"},{"key":"5555_CR20","doi-asserted-by":"publisher","unstructured":"Nemerow GR, Cooper NR (1984) Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus is blocked by calmodulin antagonists. Proc Natl AcadSci USA 81:4955-4959.https:\/\/doi.org\/10.1073\/pnas.81.15.4955","DOI":"10.1073\/pnas.81.15.4955"},{"key":"5555_CR21","doi-asserted-by":"publisher","unstructured":"Ochiai H, Kurokawa M, Niwayama S (1991) Influence of trifluoperazine on the late stage of influenza virus infection in MDCK cells. Antiviral Res15:149-160.https:\/\/doi.org\/10.1016\/0166-3542(91)90032-M","DOI":"10.1016\/0166-3542(91)90032-M"},{"key":"5555_CR22","doi-asserted-by":"publisher","unstructured":"Candurra NA, Maskin L, Damonte EB (1996) Inhibition of arenavirus multiplication in vitro by phenotiazines. Antiviral Res 31:149-158.https:\/\/doi.org\/10.1016\/0166-3542(96)06956-2","DOI":"10.1016\/0166-3542(96)06956-2"},{"key":"5555_CR23","doi-asserted-by":"publisher","unstructured":"Xiao X, Wang C, Chang D, Wang Y, Dong X, Jiao T, Zhao Z, Ren L, Dela Cruz CS, Sharma L, Lei X, Wang J (2020) Identification of potent and safe antiviral therapeutic candidates against SARS-CoV-2. Front Immunol 11:586572.https:\/\/doi.org\/10.3389\/fimmu.2020.586572","DOI":"10.3389\/fimmu.2020.586572"},{"key":"5555_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2007.01.043","volume":"363","author":"LB Talarico","year":"2007","unstructured":"Talarico LB, Damonte EB (2007) Interference in dengue virus adsorption and uncoating by carrageenans. Virology 363:473485. https:\/\/doi.org\/10.1016\/j.virol.2007.01.043","journal-title":"Virology"},{"issue":"9","key":"5555_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044835","volume":"7","author":"EG Acosta","year":"2012","unstructured":"Acosta EG, Castilla V, Damonte EB (2012) Differential Requirements in Endocytic Trafficking for Penetration of Dengue Virus. PLoS ONE 7(9):e44835. https:\/\/doi.org\/10.1371\/journal.pone.0044835","journal-title":"PLoS ONE"},{"key":"5555_CR26","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","volume":"17","author":"W Dejnirattisai","year":"2016","unstructured":"Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, Sakuntabhai A, Cao-Lormeau VM, Malasit P, Rey FA, Mongkolsapaya J, Screaton GR (2016) Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol 17:1102\u20131108. https:\/\/doi.org\/10.1038\/ni.3515","journal-title":"Nat Immunol"},{"key":"5555_CR27","doi-asserted-by":"publisher","unstructured":"Rico-Mendoza A, Porras-Ram\u00edrez A, Chang A, Encinales L, Lynch R (2019) Co- circulation of dengue, chikungunya, and Zika viruses in Colombia from 2008 to 2018. Rev PanamSaludPublica43:e49.https:\/\/doi.org\/10.26633\/RPSP.2019.49","DOI":"10.26633\/RPSP.2019.49"},{"key":"5555_CR28","doi-asserted-by":"publisher","unstructured":"Rothan HA, Bidokhti MRM, Byrareddyb SN (2018) Current concerns and perspectives on Zika virus co-infection with Arboviruses and HIV. J Autoimmun89:11-20.https:\/\/doi.org\/10.1016\/j.jaut.2018.01.002","DOI":"10.1016\/j.jaut.2018.01.002"},{"key":"5555_CR29","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1128\/AAC.02593-12","volume":"57","author":"AM Chamoun-Emanuelli","year":"2013","unstructured":"Chamoun-Emanuelli AM, Pecheur EI, Simeon RL, Huang D, Cremer PS, Chen Z (2013) Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes. Antimicrob Agents Chemother 57:2571\u20132581. https:\/\/doi.org\/10.1128\/AAC.02593-12","journal-title":"Antimicrob Agents Chemother"},{"key":"5555_CR30","doi-asserted-by":"publisher","unstructured":"Perin PM, Haid S, Brown RJ, Doerrbecker J, Schulze K, Zeilinger C, von Schaewen M, Heller B, Vercauteren K, Luxenburger E, Baktash YM, Vondran FW, Speerstra S, Awadh A, Mukhtarov F, Schang LM, Kirschning A, M\u00fcller R, Guzman CA, Kaderali L, Randall G, Meuleman P, Ploss A, Pietschmann T (2016)Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1. Hepatology 63:49-62.https:\/\/doi.org\/10.1002\/hep.28111","DOI":"10.1002\/hep.28111"},{"key":"5555_CR31","doi-asserted-by":"publisher","unstructured":"Bautista-Carvajal P, Soto-Acosta R, Angel-Ambrocio AH, Cervantes-Salazar M, Loranca-Vega CI, Herrera-Martinez M, del Angel RM (2017) The calmodulin antagonist W-7 (N-(6-aminohexyl)-5-chloro-1-naphthalaenesulfonamide hydrochloride) inhibits DENV infection in Huh-7 cells. Virology 501:188-198.https:\/\/doi.org\/10.1016\/j.virol.2016.12.004","DOI":"10.1016\/j.virol.2016.12.004"},{"key":"5555_CR32","doi-asserted-by":"publisher","unstructured":"Chen W-C, Simanjuntak Y, Chu L-W, Ping Y-H, Lee Y-L, Lin, Y-L, Li W-S (2020) Benzene sulfonamide derivatives as calcium\/calmodulin-dependent prote\u00edna kinase inhibitors and antiviral agents against dengue and Zika virus infections. J Med Chem 63:1313-1327.https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01779","DOI":"10.1021\/acs.jmedchem.9b01779"},{"key":"5555_CR33","doi-asserted-by":"publisher","unstructured":"Ho M-R, Tsai T-T, Chen C-L, Jhan M-K, Tsai C-C, Lee Y-C, Chen C-H, Lin C-F (2017) Blockade of dengue virus infection and viral cytotoxicity in neuronal cells in vitro and in vivo by targeting endocytic pathways. Sci Rep 7:6910.https:\/\/doi.org\/10.1038\/s41598-017-07023-z","DOI":"10.1038\/s41598-017-07023-z"},{"key":"5555_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.606743","volume":"10","author":"T-J Shen","year":"2021","unstructured":"Shen T-J, Hanh VT, Nguyen TQ, Jhan M-K, Ho M-R, Lin C-F (2021) Repurposing the antiemetic metoclopramide as an antiviral against dengue virus infection in neuronal cells. Front Cell Infect Microbiol 10:606743. https:\/\/doi.org\/10.3389\/fcimb.2020.606743","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-022-05555-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-022-05555-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-022-05555-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:56:07Z","timestamp":1744156567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-022-05555-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["5555"],"URL":"https:\/\/doi.org\/10.1007\/s00705-022-05555-y","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"assertion":[{"value":"28 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All data generated and analysed during this study are available in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}}]}}